Apheresis Devices Market Size, Share, Trends, Growth Outlook

Apheresis Devices Market is estimated to increase at a growth rate of 9.6% CAGR over the forecast period from 2024 to 2030.

The global Apheresis Devices Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (Membrane Filtration, Centrifugation), By Product (Disposable apheresis kits, Device), By Application (Renal diseases, Hematology, Neurology, Others), By Procedure (Plasmapheresis, LDL-apheresis, Plateletpheresis, Leukapheresis, Photopheresis, Erythrocytapheresis, Others).

An Introduction to Apheresis Devices Market in 2024

The Apheresis Devices Market in 2024 addresses medical devices used in therapeutic apheresis procedures for removing specific blood components, toxins, and disease-causing substances from patients' bloodstreams, supporting autoimmune disease management, blood disorders treatment, and organ transplantation. These apheresis devices include centrifugal separators, membrane filtration systems, and plasma exchange devices, offering extracorporeal blood purification, immune modulation, and plasma component collection. With a focus on therapeutic plasma exchange (TPE), red cell exchange (RCE), and leukapheresis techniques, apheresis devices play a crucial role in disease treatment, immune system modulation, and blood product preparation in clinical settings.

Apheresis Devices Market Competitive Landscape

The global Apheresis Devices Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Apheresis Devices Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Apheresis Devices Industry include- Asahi Kasei Corp, B. Braun SE, BioIVT LLC, Cerus Corp, Charles River Laboratories International Inc, Demophorius Ltd, Fresenius Medical Care AG and Co. KGaA, Haemonetics Corp, Haier Biomedical, Infomed SA, Kaneka Medix Corp, Kawasumi Laboratories Inc, Lmb Technologie GmbH, Mallinckrodt Plc, Medica SpA, Miltenyi Biotec B.V. and Co. KG, Nikkiso Co. Ltd, Otsuka Electronics Co. Ltd, Sichuan Nigale Biomedical Co. Ltd, Terumo Corp.

Apheresis Devices Market Trend: Enhanced Therapeutic Efficacy and Patient Safety

In the Apheresis Devices market, a significant trend is the focus on enhancing therapeutic efficacy and patient safety. With advancements in medical technology and procedural techniques, there's a growing emphasis on developing apheresis devices that offer improved efficiency, precision, and safety profiles for therapeutic plasma exchange (TPE), cytapheresis, and immunoadsorption procedures. This trend drives market growth by increasing the adoption of apheresis therapies for a wide range of autoimmune disorders, hematologic malignancies, and neurologic conditions, while minimizing adverse events, procedure-related complications, and treatment-associated risks for patients.

Apheresis Devices Market Driver: Rising Prevalence of Chronic and Rare Diseases

A key driver for the Apheresis Devices market is the rising prevalence of chronic and rare diseases that require apheresis-based therapies. Conditions such as autoimmune disorders, hematologic malignancies, neurologic diseases, and transplant-related complications are on the rise globally, driving demand for apheresis procedures as an essential component of disease management and treatment. Additionally, advancements in diagnostic techniques, disease awareness campaigns, and healthcare infrastructure contribute to early diagnosis, improved patient survival, and increased utilization of apheresis therapies, fueling market demand for apheresis devices and consumables.

Apheresis Devices Market Opportunity: Development of Next-Generation Apheresis Technologies

An opportunity exists in the development of next-generation apheresis technologies to address evolving clinical needs and therapeutic challenges. By leveraging innovations in device engineering, biomaterials, and automation systems, there's potential to enhance the efficiency, scalability, and versatility of apheresis procedures, enabling customized treatment regimens, optimized patient outcomes, and cost-effective healthcare delivery. This includes the exploration of novel apheresis modalities such as photopheresis, extracorporeal photopheresis (ECP), and immune cell isolation techniques, as well as the integration of real-time monitoring, feedback mechanisms, and artificial intelligence (AI) algorithms to improve treatment precision, safety monitoring, and patient management in the Apheresis Devices segment. Additionally, collaborating with key opinion leaders, research institutions, and regulatory agencies can facilitate technology validation, clinical validation, and market adoption of next-generation apheresis platforms, further driving innovation and growth in the apheresis therapy market.

Market Share Analysis: Membrane Filtration Apheresis Devices is the fastest growing segment in the Apheresis Devices industry

Among the various technologies utilized in apheresis devices, membrane filtration stands out as the fastest-growing segment. This growth is primarily driven by several factors. Membrane filtration technology offers several advantages over traditional centrifugation methods, including enhanced efficiency, reduced processing time, and improved selectivity in separating blood components. These devices are increasingly being adopted for therapeutic apheresis procedures in the treatment of various conditions, including renal diseases, hematological disorders, and neurological conditions. In particular, membrane filtration apheresis devices are gaining traction in applications such as plasmapheresis, LDL-apheresis, and leukapheresis, where precise and efficient separation of blood components is critical for therapeutic efficacy. Additionally, the rising prevalence of chronic diseases requiring apheresis treatment, coupled with advancements in membrane technology and device design, is driving the demand for membrane filtration apheresis devices. With ongoing research and development efforts aimed at improving the performance and versatility of these devices, the market for membrane filtration apheresis devices is poised for significant growth in the coming years.

Apheresis Devices Market Segmentation

By Technology
Membrane Filtration
Centrifugation
By Product
Disposable apheresis kits
Device
By Application
Renal diseases
Hematology
Neurology
Others
By Procedure
Plasmapheresis
LDL-apheresis
Plateletpheresis
Leukapheresis
Photopheresis
Erythrocytapheresis
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Apheresis Devices Companies

Asahi Kasei Corp
B. Braun SE
BioIVT LLC
Cerus Corp
Charles River Laboratories International Inc
Demophorius Ltd
Fresenius Medical Care AG and Co. KGaA
Haemonetics Corp
Haier Biomedical
Infomed SA
Kaneka Medix Corp
Kawasumi Laboratories Inc
Lmb Technologie GmbH
Mallinckrodt Plc
Medica SpA
Miltenyi Biotec B.V. and Co. KG
Nikkiso Co. Ltd
Otsuka Electronics Co. Ltd
Sichuan Nigale Biomedical Co. Ltd
Terumo Corp
* List not Exhaustive

Reasons to Buy the Apheresis Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Apheresis Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Apheresis Devices Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Apheresis Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Apheresis Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Apheresis Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Apheresis Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Apheresis Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Apheresis Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Apheresis Devices Industry
4.2 Key Market Trends in Apheresis Devices Industry
4.3 Potential Opportunities in Apheresis Devices Industry
4.4 Key Challenges in Apheresis Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Apheresis Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Apheresis Devices Market Outlook by Segments
7.1 Apheresis Devices Market Outlook by Segments, $ Million, 2021- 2030
By Technology
Membrane Filtration
Centrifugation
By Product
Disposable apheresis kits
Device
By Application
Renal diseases
Hematology
Neurology
Others
By Procedure
Plasmapheresis
LDL-apheresis
Plateletpheresis
Leukapheresis
Photopheresis
Erythrocytapheresis
Others
8 North America Apheresis Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Apheresis Devices Markets in 2024
8.2 North America Apheresis Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Apheresis Devices Market size Outlook by Segments, 2021-2030
By Technology
Membrane Filtration
Centrifugation
By Product
Disposable apheresis kits
Device
By Application
Renal diseases
Hematology
Neurology
Others
By Procedure
Plasmapheresis
LDL-apheresis
Plateletpheresis
Leukapheresis
Photopheresis
Erythrocytapheresis
Others
9 Europe Apheresis Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Apheresis Devices Markets in 2024
9.2 Europe Apheresis Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Apheresis Devices Market Size Outlook by Segments, 2021-2030
By Technology
Membrane Filtration
Centrifugation
By Product
Disposable apheresis kits
Device
By Application
Renal diseases
Hematology
Neurology
Others
By Procedure
Plasmapheresis
LDL-apheresis
Plateletpheresis
Leukapheresis
Photopheresis
Erythrocytapheresis
Others
10 Asia Pacific Apheresis Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Apheresis Devices Markets in 2024
10.2 Asia Pacific Apheresis Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Apheresis Devices Market size Outlook by Segments, 2021-2030
By Technology
Membrane Filtration
Centrifugation
By Product
Disposable apheresis kits
Device
By Application
Renal diseases
Hematology
Neurology
Others
By Procedure
Plasmapheresis
LDL-apheresis
Plateletpheresis
Leukapheresis
Photopheresis
Erythrocytapheresis
Others
11 South America Apheresis Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Apheresis Devices Markets in 2024
11.2 South America Apheresis Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Apheresis Devices Market size Outlook by Segments, 2021-2030
By Technology
Membrane Filtration
Centrifugation
By Product
Disposable apheresis kits
Device
By Application
Renal diseases
Hematology
Neurology
Others
By Procedure
Plasmapheresis
LDL-apheresis
Plateletpheresis
Leukapheresis
Photopheresis
Erythrocytapheresis
Others
12 Middle East and Africa Apheresis Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Apheresis Devices Markets in 2024
12.2 Middle East and Africa Apheresis Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Apheresis Devices Market size Outlook by Segments, 2021-2030
By Technology
Membrane Filtration
Centrifugation
By Product
Disposable apheresis kits
Device
By Application
Renal diseases
Hematology
Neurology
Others
By Procedure
Plasmapheresis
LDL-apheresis
Plateletpheresis
Leukapheresis
Photopheresis
Erythrocytapheresis
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Asahi Kasei Corp
B. Braun SE
BioIVT LLC
Cerus Corp
Charles River Laboratories International Inc
Demophorius Ltd
Fresenius Medical Care AG and Co. KGaA
Haemonetics Corp
Haier Biomedical
Infomed SA
Kaneka Medix Corp
Kawasumi Laboratories Inc
Lmb Technologie GmbH
Mallinckrodt Plc
Medica SpA
Miltenyi Biotec B.V. and Co. KG
Nikkiso Co. Ltd
Otsuka Electronics Co. Ltd
Sichuan Nigale Biomedical Co. Ltd
Terumo Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Technology
Membrane Filtration
Centrifugation
By Product
Disposable apheresis kits
Device
By Application
Renal diseases
Hematology
Neurology
Others
By Procedure
Plasmapheresis
LDL-apheresis
Plateletpheresis
Leukapheresis
Photopheresis
Erythrocytapheresis
Others